About this trial
This study investigates the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on cognitive performance in healthy adults. The study uses a sham-controlled, cross-over design in which each participant receives both active taVNS and sham stimulation in separate sessions. Each participant completes both conditions (active and sham) in a randomized order using a crossover design. Cognitive performance will be assessed before and after each session using standardized tests. The study also explores whether males and females respond differently to taVNS, in order to identify potential sex-related differences in cognitive outcomes.
Eligibility criteria
Qualifiers
Healthy young adults aged 18-30 years
Ability to provide informed consent
Right-handed participants (to reduce variability in cognitive performance)
Normal or corrected-to-normal vision and hearing
Disqualifiers
History of neurological or psychiatric disorders
Cardiovascular disease
Use of psychoactive medications
Substance dependence, including alcohol, illicit drugs, or nicotine
Trial design
Treatments tested in this trial
- Active taVNS
- Sham Stimulation